GLAXO.BO
GlaxoSmithKline Pharmaceuticals Limited
BSEINREQUITY
Healthcare
DELAYED
Last price
2,899.60
▼ 100.35 (3.35%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
2,992.55
Prev close
2,999.95
Day high
2,992.55
Day low
2,875.00
Volume
6.54K
Market cap
$491.21B
P/E (TTM)
51.50
52W range
1,968.00 – 3,515.95
Day trading desk
Gap from prior close
—
—
VWAP
2,926.40
-0.92% from price
Relative volume
1.43×
Normal
Session range
4.09%
2,875.00 – 2,992.55
Position in range
21%
Near session low
ATR (14D)
—
Daily true range
Prior day high
—
PDH
Prior day low
—
PDL
Bid / ask spread
—
Quote not published
Session volume
6.25K
Avg 4.37K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on GLAXO.BO open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
128.15M
Total on file
Fundamentals
Market cap$491.21B
Enterprise value$393.61B
Revenue (TTM)$37.09B
Gross profit$23.32B
EBITDA$11.87B
Net income$9.55B
EPS (TTM)$56.30
Free cash flow$6.18B
Total cash$20.61B
Total debt$357.10M
Book value / share$100.81
Shares outstanding169.41M
Float41.25M
Short % of float—
Dividend yield1.75%
Beta (5Y)-0.05
Valuation & profitability ratios
Trailing P/E51.50
Forward P/E42.78
PEG ratio—
Price / sales—
Price / book28.76
EV / revenue10.61
EV / EBITDA33.15
Gross margin62.86%
Operating margin32.48%
Profit margin25.76%
Return on equity56.52%
Return on assets19.39%
Debt / equity2.09
Current ratio1.78
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Total revenue | $38.08B | $37.26B | $34.42B | $32.26B | +2.2% |
| Operating revenue | $38.08B | $37.26B | $34.42B | $32.26B | +2.2% |
| Cost of revenue | $14.22B | $14.73B | $14.20B | $13.59B | -3.5% |
| Gross profit | $23.86B | $22.53B | $20.22B | $18.68B | +5.9% |
| Selling, general & admin | $2.49B | $2.39B | $2.28B | $2.07B | +4.1% |
| Total operating expense | $11.38B | $11.39B | $11.83B | $11.19B | -0.0% |
| Operating income | $12.48B | $11.14B | $8.38B | $7.48B | +12.0% |
| Net interest income | $539.96M | $700.66M | $660.52M | $680.00M | -22.9% |
| Pre-tax income | $14.06B | $12.60B | $8.16B | $8.36B | +11.6% |
| Tax provision | $3.70B | $3.32B | $2.26B | $2.29B | +11.4% |
| Net income | $10.36B | $9.28B | $5.90B | $6.11B | +11.7% |
| Net income to common | $10.36B | $9.28B | $5.90B | $6.11B | +11.7% |
| EBIT | $14.09B | $12.61B | $8.18B | $8.38B | +11.7% |
| EBITDA | $14.75B | $13.28B | $8.88B | $9.04B | +11.1% |
| Line item | 2026 | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $11.02B | $5.39B | $641.71M | $349.41M | — | +104.5% |
| Cash & short-term investments | $27.56B | $24.98B | $18.57B | $16.54B | — | +10.3% |
| Accounts receivable | $2.73B | $2.93B | $2.22B | $1.92B | — | -6.6% |
| Inventory | $4.58B | $4.82B | $5.25B | $4.60B | — | -5.0% |
| Total current assets | $36.07B | $34.10B | $27.98B | $24.94B | — | +5.8% |
| Property, plant & equipment | $3.06B | $2.84B | $3.11B | $3.15B | — | +8.0% |
| Goodwill & intangibles | $65.56M | $133.32M | $235.54M | $340.91M | — | -50.8% |
| Total assets | $43.24B | $41.08B | $35.57B | $33.27B | — | +5.3% |
| Total current liabilities | $17.79B | $19.05B | $15.25B | $13.26B | — | -6.6% |
| Current debt | — | — | — | — | $0 | — |
| Total debt | $332.72M | $99.51M | $186.65M | $155.39M | — | +234.4% |
| Total liabilities | $20.56B | $21.57B | $17.79B | $15.85B | — | -4.7% |
| Retained earnings | $13.83B | $10.59B | $8.76B | $8.11B | — | +30.7% |
| Shareholder equity | $22.67B | $19.51B | $17.78B | $17.41B | — | +16.2% |
| Working capital | $18.28B | $15.05B | $12.73B | $11.68B | — | +21.5% |
| Net tangible assets | $22.61B | $19.38B | $17.54B | $17.07B | — | +16.7% |
| Shares issued | 169.41M | 169.41M | 169.41M | 169.41M | — | 0.0% |
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Net income | $13.85B | $12.55B | $9.60B | $8.41B | +10.4% |
| Depreciation & amortisation | $664.44M | $667.92M | $696.80M | $657.67M | -0.5% |
| Change in working capital | -$981.67M | $1.85B | $610.21M | -$457.46M | -153.1% |
| Operating cash flow | $9.03B | $12.90B | $5.82B | $4.84B | -30.0% |
| Capital expenditure | -$552.79M | -$247.22M | -$312.21M | -$440.39M | -123.6% |
| Investing cash flow | $3.97B | -$458.01M | $87.12M | $8.08B | +966.8% |
| Dividends paid | -$7.14B | -$7.49B | -$5.42B | -$15.25B | +4.7% |
| Financing cash flow | -$7.37B | -$7.69B | -$5.61B | -$15.43B | +4.2% |
| Free cash flow | $8.48B | $12.65B | $5.51B | $4.40B | -33.0% |
| End cash position | $11.02B | $5.39B | $641.71M | $349.41M | +104.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $9.38B | $9.95B | $10.41B | $8.05B | $9.74B | -5.7% |
| Operating revenue | $9.38B | $9.95B | $10.41B | $8.05B | $9.74B | -5.7% |
| Cost of revenue | $3.28B | $3.44B | $3.64B | $2.88B | $3.52B | -4.7% |
| Gross profit | $6.11B | $6.51B | $6.77B | $5.17B | $6.22B | -6.3% |
| Total operating expense | $3.31B | $3.14B | $3.26B | $2.82B | $3.04B | +5.5% |
| Operating income | $2.80B | $3.38B | $3.51B | $2.36B | $3.18B | -17.2% |
| Net interest income | -$9.70M | -$6.10M | -$11.90M | -$4.20M | -$5.80M | -59.0% |
| Pre-tax income | $3.22B | $3.73B | $4.00B | $2.79B | $3.59B | -13.6% |
| Tax provision | $852.70M | $952.40M | $1.04B | $739.70M | $957.00M | -10.5% |
| Net income | $2.37B | $2.78B | $2.96B | $2.05B | $2.63B | -14.6% |
| Net income to common | $2.37B | $2.78B | $2.96B | $2.05B | $2.63B | -14.6% |
| EBIT | $3.23B | $3.74B | $4.01B | $2.79B | $3.59B | -13.5% |
| EBITDA | $3.39B | $3.87B | $4.21B | $2.95B | $3.74B | -12.3% |
| Line item | 2026-03-31 | 2025-03-31 | YoY |
|---|---|---|---|
| Cash & equivalents | $11.02B | $5.39B | +104.5% |
| Cash & short-term investments | $27.56B | $24.98B | +10.3% |
| Accounts receivable | $2.73B | $2.93B | -6.6% |
| Inventory | $4.58B | $4.82B | -5.0% |
| Total current assets | $36.07B | $34.10B | +5.8% |
| Property, plant & equipment | $3.06B | $2.84B | +8.0% |
| Goodwill & intangibles | $65.56M | $133.32M | -50.8% |
| Total assets | $43.24B | $41.08B | +5.3% |
| Total current liabilities | $17.79B | $19.05B | -6.6% |
| Total debt | $332.72M | $99.51M | +234.4% |
| Total liabilities | $20.56B | $21.57B | -4.7% |
| Retained earnings | $13.83B | $10.59B | +30.7% |
| Shareholder equity | $22.67B | $19.51B | +16.2% |
| Working capital | $18.28B | $15.05B | +21.5% |
| Net tangible assets | $22.61B | $19.38B | +16.7% |
| Shares issued | 169.41M | 169.41M | 0.0% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $10.27B | +8.2% |
| Next quarter | — | — | $10.62B | +8.9% |
| Current year | 60.68 | 4 | $38.69B | +3.2% |
| Next year | 67.78 | 4 | $41.70B | +7.8% |
Analyst targets & ownership
Mean target$2,943.25
High target$3,500.00
Low target$2,500.00
Implied upside1.51%
Analyst count4
ConsensusNONE
Strong buy / Buy0 / 2
Hold2
Sell / Strong sell0 / 0
Held by insiders75.65%
Held by institutions8.51%
Institutions holding80
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
—
—
SMA 20
—
—
SMA 50
—
—
SMA 100
—
—
SMA 200
—
—
EMA 12
—
—
EMA 26
—
—
EMA 50
—
—
RSI (14)
—
—
MACD (12,26,9)
—
Hist —
ATR (14)
—
—
Realised vol 30D
—
Annualised
Bollinger upper
—
20, 2σ
Bollinger lower
—
20, 2σ
50 / 200 cross
—
—
Trend bias
—
—
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
—
—
Correlation to SPY
—
—
Realised vol 30D
—
Annualised
Market vol 1Y
—
SPY, annualised
Max drawdown 1Y
—
Peak to trough
Max drawdown 5Y
—
Peak to trough
ATR 14
—
Average true range
Beta (reported)
-0.05
5Y monthly, from filing
Dividends & splits
Forward rate$42.00 / yr
Forward yield1.75%
5-year avg yield1.73%
Payout ratio74.48%
Ex-dividend dateMay 30, 2025
Next pay date—
Last split2:1
Split dateSep 11, 2018
Headlines
Cardinal Health's CEO Moved 124,529 Shares in Two Days. Here's What Long-Term Investors Should Know
Motley Fool · 11m ago
After Biggest One-Day Decline Since 2022, Is Walmart Stock a Buy?
Motley Fool · 21m ago
He Was Laid Off at 63 and Thought Social Security Ruled Out Unemployment. He Was Wrong.
24/7 Wall St. · 26m ago
A 22-year-old inherited $1.7 million after her mom's sudden death. These are the tax and IRS rules she needs to know now
Moneywise · 26m ago
Nvidia Reportedly Warns Top Customers of 15% Price Hikes on AI Servers
BeInCrypto · 28m ago
Bitcoin slips under $77,000 as rally boosts mining economics
Investing.com · 28m ago
Anthropic Could Outdo SpaceX With Its IPO. Here's How Much Investors Think It's Worth Right Now and Why.
Motley Fool · 31m ago
Billionaire David Tepper Has 16% of His $7.5 Billion Appaloosa Portfolio in Amazon Stock. Is It Still a Buy?
Motley Fool · 34m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.